Semra Hız Kurul
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Semra Hız Kurul has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
- Uluç Yiş
Dokuz Eylul University Children's Hospital, Department of Pediatric Neurology, Izmir, Turkey
7 shared publications - Erhan Bayram
Dokuz Eylül University Medical Faculty
5 shared publications Derya Okur
4 shared publicationsMuge Ayanoglu
4 shared publicationsPinar Edem
4 shared publicationsCem Paketci
3 shared publications
Latest Publications
- Open Access
Biallelic ATG9B Variants Define a Novel Autophagy-Related Neurodevelopmental Disorder with Cerebellar Ataxia
Background/Objectives: Autophagy is a highly conserved eukaryotic cellular process whose dysfunction results in human pathologies including cancer and neurodegenerative disease. First identified in yeast, ATG genes are central players in autophagy. Mutations in core autophagy genes ATG5 and ATG7 have been previously reported to cause rare genetic disorders with autosomal recessive inheritance. Methods: Here we report, for the first time, variants in human ATG9B gene as causative factors for a rare neurodevelopmental disease with autosomal recessive inheritance. Three distinct mutations were detected in three independent families with consanguinity, five patients affected in total. Results: The first variant is an 11-nucleotide deletion resulting in a frameshift. A premature stop codon is added and the C-terminal cytosolic domain of ATG9B protein is truncated. The second one is a point mutation that changes a critical amino acid in the transmembrane domain. The third variant is a 2-nucleotide deletion causing a different truncation product. Patients presented with diverse neurodevelopmental anomalies including intellectual disability, behavioral abnormalities, congenital cerebellar ataxia, mild cerebellar atrophy, and microcephaly. Since human ATG9B is expressed specifically in the placenta, we hypothesized that the disease pathology originates during placental development. To characterize the effects of the first frameshift mutation and gain insight into the specific functions of ATG9B in a physiological setting, we used mammalian cells and a knock-in mouse model. Truncated ATG9B was not stable when expressed in cells. It was localized to perinuclear vesicles like the WT protein, but not to peripheral vesicles. Homozygous knock-in mice were viable, fertile, and displayed no gross phenotypical abnormalities. Histomorphometry analysis of the placenta layers did not reveal a significant difference between mutant and control embryos. The assessments of neurobehavioral tests were similar in wild-type and homozygous knock-in mice. However, knock-in mice had a reduced fear memory trend, which is an amygdala-involved response. Conclusions: In this study, we describe a new rare disease linked to ATG9, including cerebellar ataxia and atrophy, as described for ATG5 and ATG7.
Open AccessBiallelic ATG9B Variants Define a Novel Autophagy-Related Neurodevelopmental Disorder with Cerebellar Ataxia
Background/Objectives: Autophagy is a highly conserved eukaryotic cellular process whose dysfunction results in human pathologies including cancer and neurodegenerative disease. First identified in yeast, ATG genes are central players in autophagy. Mutations in core autophagy genes ATG5 and ATG7 have been previously reported to cause rare genetic disorders with autosomal recessive inheritance. Methods: Here we report, for the first time, variants in human ATG9B gene as causative factors for a rare neurodevelopmental disease with autosomal recessive inheritance. Three distinct mutations were detected in three independent families with consanguinity, five patients affected in total. Results: The first variant is an 11-nucleotide deletion resulting in a frameshift. A premature stop codon is added and the C-terminal cytosolic domain of ATG9B protein is truncated. The second one is a point mutation that changes a critical amino acid in the transmembrane domain. The third variant is a 2-nucleotide deletion causing a different truncation product. Patients presented with diverse neurodevelopmental anomalies including intellectual disability, behavioral abnormalities, congenital cerebellar ataxia, mild cerebellar atrophy, and microcephaly. Since human ATG9B is expressed specifically in the placenta, we hypothesized that the disease pathology originates during placental development. To characterize the effects of the first frameshift mutation and gain insight into the specific functions of ATG9B in a physiological setting, we used mammalian cells and a knock-in mouse model. Truncated ATG9B was not stable when expressed in cells. It was localized to perinuclear vesicles like the WT protein, but not to peripheral vesicles. Homozygous knock-in mice were viable, fertile, and displayed no gross phenotypical abnormalities. Histomorphometry analysis of the placenta layers did not reveal a significant difference between mutant and control embryos. The assessments of neurobehavioral tests were similar in wild-type and homozygous knock-in mice. However, knock-in mice had a reduced fear memory trend, which is an amygdala-involved response. Conclusions: In this study, we describe a new rare disease linked to ATG9, including cerebellar ataxia and atrophy, as described for ATG5 and ATG7.
- 8 April 2026
- Published by Elsevier in Epilepsy Research
- Vol. 224, 107798
The role of DHH motifs in PRUNE1 gene on ion channels: A new insight into epilepsy pathogenesis
- 8 April 2026
- Published by Elsevier in Epilepsy Research
- Vol. 224, 107798
The role of DHH motifs in PRUNE1 gene on ion channels: A new insight into epilepsy pathogenesis
- Open Access
- 20 March 2025
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 184 (4) , 1-15
Phenotypic variability in cases with CACNA1A mutation
The purpose of this study was to enhance understanding of CACNA1A gene variants by elucidating the clinical profiles of patients with different variants. The overlapping features and varying phenotypic characteristics of these neurological disorders pose challenges for clinicians. A data collection form was utilized to gather clinical features, examination details, and treatment information associated with CACNA1A variants. Thirty-one patients were included in the study from 11 different clinics in Turkey. Cases were assessed by comparing their information with existing literature. The study initially included 32 patients from 29 families, with 31 patients meeting the inclusion criteria. Clinical manifestations ranged from congenital onset hypotonia to motor seizures. Within the group of patients, 87% were diagnosed with epilepsy, 61% had neurodevelopmental defects, 32% experienced ataxia, 22% had eye movement problems, 16% suffered from migraines, and 13% had recurrent encephalopathy. Thirty percent of individuals exhibited cerebellar atrophy. A subset of individuals exhibited various forms of cognitive impairment and different kinds of ataxia. Conclusion: CACNA1A variants can lead to structural and functional abnormalities in the Cav2.1 channels, resulting in paroxysmal and/or chronic clinical presentations. The overlapping phenotypes and variable features among family members suggest the influence of environmental factors and modifier genes. A thorough understanding of the range of phenotypic variants and the difficulties encountered by medical professionals is essential for precise diagnosis and efficient treatment approaches in various neurological conditions. Additional research is necessary to clarify the underlying mechanisms that contribute to the various presentations of these variants. What is known: • Variants in the CACNA1A gene disrupt calcium signaling, thereby impacting fundamental developmental processes such as neuronal differentiation, migration, and synapse formation. • Variants in the CACNA1A can lead to neurodevelopmental disorders characterized by intellectual disability, learning difficulties, memory challenges, and problems in social interaction. What is new: • Instances of intrafamilial variability in CACNA1A variants have been identified, with differing clinical manifestations exhibited by affected family members. • Incomplete penetrance is a phenomenon that may occur, as neurodevelopmental or neuropsychiatric findings are not exhibited by some patients with CACNA1A variants.
- 20 March 2025
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 184 (4) , 1-15
Open AccessPhenotypic variability in cases with CACNA1A mutation
The purpose of this study was to enhance understanding of CACNA1A gene variants by elucidating the clinical profiles of patients with different variants. The overlapping features and varying phenotypic characteristics of these neurological disorders pose challenges for clinicians. A data collection form was utilized to gather clinical features, examination details, and treatment information associated with CACNA1A variants. Thirty-one patients were included in the study from 11 different clinics in Turkey. Cases were assessed by comparing their information with existing literature. The study initially included 32 patients from 29 families, with 31 patients meeting the inclusion criteria. Clinical manifestations ranged from congenital onset hypotonia to motor seizures. Within the group of patients, 87% were diagnosed with epilepsy, 61% had neurodevelopmental defects, 32% experienced ataxia, 22% had eye movement problems, 16% suffered from migraines, and 13% had recurrent encephalopathy. Thirty percent of individuals exhibited cerebellar atrophy. A subset of individuals exhibited various forms of cognitive impairment and different kinds of ataxia. Conclusion: CACNA1A variants can lead to structural and functional abnormalities in the Cav2.1 channels, resulting in paroxysmal and/or chronic clinical presentations. The overlapping phenotypes and variable features among family members suggest the influence of environmental factors and modifier genes. A thorough understanding of the range of phenotypic variants and the difficulties encountered by medical professionals is essential for precise diagnosis and efficient treatment approaches in various neurological conditions. Additional research is necessary to clarify the underlying mechanisms that contribute to the various presentations of these variants. What is known: • Variants in the CACNA1A gene disrupt calcium signaling, thereby impacting fundamental developmental processes such as neuronal differentiation, migration, and synapse formation. • Variants in the CACNA1A can lead to neurodevelopmental disorders characterized by intellectual disability, learning difficulties, memory challenges, and problems in social interaction. What is new: • Instances of intrafamilial variability in CACNA1A variants have been identified, with differing clinical manifestations exhibited by affected family members. • Incomplete penetrance is a phenomenon that may occur, as neurodevelopmental or neuropsychiatric findings are not exhibited by some patients with CACNA1A variants.
- 1 June 2017
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 21, e156
Riboflavin responsive neuromusculary disorders; broad phenotypic spectrum and importance of genetic analyses
- 1 June 2017
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 21, e156
Riboflavin responsive neuromusculary disorders; broad phenotypic spectrum and importance of genetic analyses
- 1 June 2017
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 21, e228
Nerve conduction study findings in children with cystic fibrosis
- 1 June 2017
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 21, e228
Nerve conduction study findings in children with cystic fibrosis
- 1 June 2017
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 21, e36-e37
Alternative medications for epilepsy of infancy with migrating focal seizures; Potassium bromide and ketogenic diet
- 1 June 2017
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 21, e36-e37
Alternative medications for epilepsy of infancy with migrating focal seizures; Potassium bromide and ketogenic diet
- 1 June 2017
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 21, e117
Anti-MOG positive pediatric cases with diverse clinical spectrum in demyelinating disorders
- 1 June 2017
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 21, e117
Anti-MOG positive pediatric cases with diverse clinical spectrum in demyelinating disorders
- 1 October 2015
- Published by SLACK, Inc. in Pediatric Annals
- Vol. 44 (10) , 426-432
An 11-Year-Old Boy with Headache, Fever, and Neck Pain
Pediatric Annals | Editor’s note: Each month, this department features a discussion of an unusual diagnosis. A description and images are presented, followed by the diagnosis and an explanation of how the diagnosis was determined. As always, your comments are welcome via email at pedann@Healio.com. An 11-year-old-boy was admitted to the pediatric emergency department with 5 days of headache that was
- 1 October 2015
- Published by SLACK, Inc. in Pediatric Annals
- Vol. 44 (10) , 426-432
An 11-Year-Old Boy with Headache, Fever, and Neck Pain
Pediatric Annals | Editor’s note: Each month, this department features a discussion of an unusual diagnosis. A description and images are presented, followed by the diagnosis and an explanation of how the diagnosis was determined. As always, your comments are welcome via email at pedann@Healio.com. An 11-year-old-boy was admitted to the pediatric emergency department with 5 days of headache that was
- 12 February 2014
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 50 (7) , 553-556
The efficacy and safety of levetiracetam in paediatric patients treated with chemotherapeutic agents for haematologic disorders
- 12 February 2014
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 50 (7) , 553-556
The efficacy and safety of levetiracetam in paediatric patients treated with chemotherapeutic agents for haematologic disorders
- 7 November 2013
- Vol. 55 (2) , 235-6
A case of atypical Miller Fisher syndrome with negative anti-GQ1b immunoglobulin G and importance of H reflex.
- 7 November 2013
- Vol. 55 (2) , 235-6
A case of atypical Miller Fisher syndrome with negative anti-GQ1b immunoglobulin G and importance of H reflex.